期刊文献+

补钙干预对柠檬酸盐抗凝剂所致机体代谢变化的影响 被引量:2

Effect of Calcium Supplement on the Changes of Serum Analysis Induced by Acute Citrate Load (ACD-A)
原文传递
导出
摘要 [目的]了解不同补钙干预方式对柠檬酸盐抗凝剂(ACD-A)所致的机体代谢变化的影响,为预防ACD-A所致低钙血症提供参考。[方法]采用自身交叉、安慰剂对照研究模式,对22名志愿者分别给予4种干预:A.输注生理盐水为安慰剂;B.仅输注ACD-A;C.ACD-A输注+口服钙片;D.ACD-A输注+静脉补钙。每一干预过程中同时采样进行血、尿电解质分析。[结果]静脉补钙可有效减缓ACD-A所致的钙离子下降趋势;口服补钙仅明显提升干预末钙离子浓度。2种补钙方式均未对血磷的变化造成影响,但均导致游离钙、磷离子浓度恢复进程加快及24h后血磷检测值升高。B、C、D法干预模式下血磷与血钙的变化密切相关,血钾与血氯的变化相关。[结论]口服补钙和静脉补钙均对ACD-A所致的血钙和磷的代谢变化有影响。用口服钙剂预防时应考虑服用时间和剂量的影响。 [Objective] To study the effect of calcium (Ca) supplement on the changes of serum analysis induced by acute citrate (ACD-A) load for hypocalcemia prevention.[Methods] A crossover and placebo study were conducted and 22 volunteers were received for 4 interventions:A,placebo (saline);B,ACD-A;C,ACD-A + oral Ca;D,ACD-A + intravenous (I.V.) of Ca.Serial blood and urinary samples were collected for analysis.[Results] I.V.Ca alleviated decreasing level of ionized calcium (iCa) in serum,while oral Ca only increased the iCa level at the end point of infusion.There were no effects on the changes of phosphate for both interventions,but expedited the recovery process of iCa and phosphate,and led to higher level of phosphate at 24 hours later.Changes of iCa and phosphate were correlated to each other for B,C,D interventions,while potassium was correlated to the chloride.[Conclusion] With oral and I.V.Ca supplements,there are effects on the levels of iCa and phosphate induced by ACD-A.Dose and time of administration should be taken into account to achieve the best effect by oral Ca supplement.
出处 《海峡预防医学杂志》 CAS 2010年第2期8-12,共5页 Strait Journal of Preventive Medicine
基金 福建省科技计划重点项目(No.2008Y0032)
关键词 补钙 低钙血症 柠檬酸盐 Calcium Supplement Hypocalcemia Citrate
  • 相关文献

参考文献14

二级参考文献25

  • 1严书梅.采血过程中献血反应的救治与预防[J].包头医学,2005,29(1):36-37. 被引量:4
  • 2孙启俊,傅强,李翠萍,欧阳建,陈津,周丽娟,张晓萍,王瑛瑛,姜士荣,朱世钧,张葵.长期机采血小板献血者甲状旁腺素测定的意义[J].中国输血杂志,2005,18(6):468-469. 被引量:19
  • 3Winters JL. Complications of Donor Apheresis. J Clin Apher, 2006, 21:132-141.
  • 4Makar YF, Butler MO, Cockersole GM, et al. National audit of citrate toxicity in plateletpheresis donors. Transfus Med ,2002,12: 183-191.
  • 5Das SS, Chaudhary R, Khetan D, et al. Calcium and magnesium levels during automated plateletpheresis in normal donors. Transfus Med, 2005,15:233-236.
  • 6Bolan CD, Greer SE, Cecco SA, et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion, 2001, 41:1165-1171.
  • 7Wang PL, Meyer MM, Orloff SL, et al. Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Am J Kidney Dis, 2004, 44 : 1110-1114.
  • 8Dettke M, Buchta C, Bieglmayer C, et al. Short and long term effects of citrate on bone metabolism and bone mineral density in healthy plateletpheresis donors. J Clin Apher, 2003, 18 : 87.
  • 9Morrison B, Shenkin A, Mclelland A et al. Intra-Individual variation in commonly analyzed serum constituents. Clin Chem, 1979, 25 : 1799-1805.
  • 10陈颖,Markus Dettke,Paul Hoecker,Christian Bieglmayer.血小板机采过程中年龄依赖性骨代谢变化分析[J].中华检验医学杂志,2007,30(8):878-881. 被引量:10

共引文献51

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部